CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cytel Inc., a global provider of clinical research services and software will highlight its continued success in delivering high quality products and outsourcing solutions to the biopharmaceutical industry at the Annual Meeting of the Drug Information Association (DIA) June 26th- 30th 2016 in Philadelphia.
Cytel, the world’s largest biometrics CRO and recognized leader in adaptive trial design, supported over 250 clinical research projects in 2015. This includes the addition of further functional partnerships in statistics and statistical programming to its portfolio.
Growth in headcount and revenue has been strong across all divisions. Cytel’s internal recruitment team successfully coordinated the onboarding of over 100 operational team members in statistics, statistical programming, and data management last year at the company’s US and EU locations. Increasing demand for its study-based and functional services will support further expansion of offices and employees.
‘Data quality, operational efficiency, and expert study design are key success factors in the delivery of clinical research services,’ said Irving Dark, Senior VP at Cytel. ‘Many sponsors are now choosing to centralize biometrics services with expert providers like Cytel to improve quality of services and reduce costs.’
Event attendees are invited to stop by Cytel’s booth 1111 to meet its clinical development experts and learn more about how the company’s biometrics outsourcing solutions can help mitigate risks, ensure efficiency, and improve data quality. To schedule a meeting in advance with one of the team contact email@example.com.
At Cytel, we’re shaping the future of drug development. Our cutting-edge software and biometrics outsourcing services enable pharmaceutical and biotechnology companies of all sizes to improve clinical success rates.